DFTX
DFTX
CA24477V1058
Definium Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.96B EUR
6.24B EUR
1.97B EUR
1.32B EUR
Enterprise Value
3.55B EUR
5.63B EUR
1.74B EUR
1.11B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-19.02x
--
--
--
Price to Sales
--
--
--
--
Price to Book
5.4x
6.8x
7.05x
3.98x
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
651.4x
--
--
--
EV/FCF
465.78x
--
--
--
FCF Yield
0.15%
-2.69%
-7.36%
-7.72%
ende